Skip to main content
. 2017 Dec 6;7:17047. doi: 10.1038/s41598-017-17270-9

Figure 2.

Figure 2

Vitamin K2 lowers ROS release. (A) Confocal microscopy showed increased ROS in Lymph gland of heix mutants, reduced by VK2 treatment. (B) Confocal microscopy showed increased ROS in Brain of heix mutants, reduced by VK2 treatment. Both lesions responded significantly to treatment. DAPI stain (blue) and ROS staining (CM-H2DCFDA) (green). Control media contain 50 mM Ethanol (EtOH) and treatment media contain 50 mM VK2. Means normalized to control (Canton S). Error bars indicate SEM. Analysis of variance (AVOVA/Dunnett: *P < 0.05, **P < 0.01, ***P < 0.001).